Focus area
Clinical Trials Investment Firms
The RaiseHunt database lists 224 Clinical Trials investment firms: 223 of them list a portfolio, 2,133 known investments between them and 1,197 people at those firms have a profile here. Most list Seed and Series A among the rounds they take part in; the largest concentrations are in New York, San Francisco and Boston.
- 224
- Investment firms
- 223
- With a known portfolio
- 2,133
- Known investments
- 1,197
- People with a profile
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
224 Clinical Trials investment firms
Showing 1-20
| Firm | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
GV Genesis Ventures | Chile | Syndicate / Angel groupVenture capital | AIClimate | View fund | |
NC Nex Cubed | Newport Beach, United States | AcceleratorVenture capital | AICommerce | View fund | |
BI BioInnovation Institute (BII) | Copenhagen, Denmark | Accelerator | ClimateFood | View fund | |
EI Elliott Investment Management | New York, United States | Private equityVenture debt | ClimateCommerce | View fund | |
CC CD Capital | Shanghai, China | Private equityVenture capital | HardwareHealthcare | View fund | |
PV Panacea Venture | United States | AcceleratorVenture capital | AIConsumer | View fund | |
A Avenir | New York, United States | Private equityVenture capital | AICommerce | View fund | |
HM Harbert Management | Birmingham, United States | Private equityVenture debt | AIClimate | View fund | |
MG Mountain Group Partners | Nashville, United States | Private equityVenture capital | ClimateConsumer | View fund | |
PC Pappas Capital | Durham, United States | Venture capital | AIHardware | View fund | |
TC TVM Capital Life Science | Montreal, Canada | Venture capital | ConsumerHardware | View fund | |
DG Debiopharm Group | Lausanne, Switzerland | Corporate VC | AIHealthcare | View fund | |
GF Geekdom Fund | San Antonio, United States | AcceleratorVenture capital | AIHardware | View fund | |
MB MPM BioImpact | Boston, United States | Private equityVenture capital | Healthcare | View fund | |
LC LYFE Capital | Singapore | Private equity | HardwareHealthcare | View fund | |
XF X Fund | Menlo Park, United States | Venture capital | AICommerce | View fund | |
A Abingworth | London, United Kingdom | Venture capital | Healthcare | View fund | |
B Benchstrength | New York, United States | Venture capital | AICommerce | View fund | |
L& Lewis & Clark Ventures | Chicago, United States | Venture capital | AICommerce | View fund | |
OV OMX Ventures | Boston, United States | Venture capital | AIHealthcare | View fund |
184 of 224 Clinical Trials investment firms, A to Z
Grouped by first letter. Name and profile link only, the detailed rows are in the table above.ShowHide
A17
- Aberdare Ventures
- Ackermans & van Haaren
- ACVC Partners
- Adage Capital Management
- Aisling Capital
- Akka Venture
- Altitude Ventures
- Amzak Health Investors
- Angelini Ventures
- Aphelion Capital
- Ardian
- Atem Capital Fund
- Atlas Venture
- ATP
- Atria Ventures
- Auriga Partners
- aws Gründungsfonds
B11
- Baptist Health
- Big Red Ventures
- Big_bets
- BioVentures Investors
- Biovision Ventures
- Boston Millennia Partners
- Bpd Partners
- Bpea
- Bristol Myers Squibb
- BroadOak Capital Partners
- BVM Capital
C12
- Careventures
- Carolina Angel Network
- Celerity Partners
- Centers for Disease Control and Prevention
- China Merchants Group
- Claris Ventures
- Club Degli Investitori
- CMIC Group
- Crédit Agricole CIB
- Crescendo Venture Partners
- CTI Life Sciences Fund
- CureDuchenne Ventures
D9
- Decheng Capital
- Deep Science Ventures
- DeepWork Capital
- Define Ventures
- DEFTA Partners
- Deutsche Private Equity (DPE)
- Dm Capital
- Dreavent
- dRx Capital
E5
- Efung Capital
- Epiris
- Eqt Life Sciences
- European Circular Bioeconomy Fund
- Extens
F8
- FACIT
- Fast Track Initiative
- Fca Venture Partners
- First Trust Capital Partners
- Florac
- Forestay Capital
- FPV Ventures
- Frist Cressey Ventures
G6
- Gaw Capital
- GBS Ventures
- GED Ventures Portugal
- Genoa Ventures
- GHO Capital Partners
- Gurnet Point Capital
H9
- Hadean Ventures
- Hambro Perks
- Hanne Capital
- HealthCare Royalty
- Healthquest Capital
- Healthy Ventures
- Helicase Venture
- Hg Initiative
- Housatonic Partners
I9
- Id Fund
- ID Ventures
- InCube Ventures
- InnovationsKapital
- Intermountain Ventures
- InvAscent
- Invent Ventures
- Israel Biotech Fund
- Ivy Capital
J3
- Jemison Investment Company
- Jmcr Partners
- Juxtapose
K3
- Kearny Venture Partners
- Kin Ventures
- Kyto Technology and Life Science
L5
- La Maison Partners
- LBO France
- Lifeforce Capital
- Logos Global Management
- LYZZ CAPITAL
M9
- McKesson Ventures
- Medequity Capital
- Medicxi
- Metrodora Ventures
- Michigan Rise
- Millennium
- Miyako Capital
- MTIP
- Mubadala Capital
N9
- Navis Capital Partners
- Necessary Ventures
- Nina Capital
- NJF Capital
- Northpond Ventures
- NovaQuest Capital Management
- Novel Capital
- NSW Health
- NV Industriebank LIOF
O4
- Ocean Azul Partners
- ODYSSEE Venture
- Orlando Health
- Overwater Ventures
P5
- PAG
- Paramark Ventures
- PBM Capital Group
- Positive Sum
- PPD
Q3
- QHP Capital
- Quad-C Management
- Quan Capital
R6
- Redmile Group
- Remiges Ventures
- Rex Health Ventures
- RiverHead Capital
- RiverVest Venture Partners
- Russia-china Investment Fund
S17
- Salmira Investment Fund
- SANTÉ
- Scion Life Sciences
- Seattle Angel Conference
- Shumway Capital
- SightLine Partners
- Sirona Capital
- Sofia Fund
- Sofinnova Partners
- Solas BioVentures
- Solus Capital
- Sonder Capital
- Sopris Capital
- Sprim Global Investments
- Spring Mountain Capital
- StandUp Ventures
- SwissHealth Ventures
T14
- Tang Capital Management
- Target ALS
- Teal Ventures
- The Baupost Group
- The LegalTech Fund
- The National Institutes of Health
- Thoma Bravo
- Thuja Capital
- TIA Ventures
- Top Harvest Capital
- TowerBrook Capital Partners
- Trans-pacific Technology Fund (tptf)
- Treo Ventures
- Trill Impact
U2
- Uniseed
- University of Nottingham
V8
- Valiance Asset Management
- Valtruis
- VC23 Capital
- Virginia Venture Partners
- Virgo Investment Group
- Virtue
- Visionary Venture Fund
- VSC Ventures
W5
- Waiv
- Whistler Capital Partners
- Willett Advisors
- WindRose Health Investors
- Wittington Ventures
X2
- Xerys
- Xontogeny
#3
- 3Ã5 Partners
- 5Lion Ventures
- 77 Capital
Frequently asked questions
How many Clinical Trials investment firms are on RaiseHunt?
RaiseHunt lists 224 Clinical Trials investment firms.
How many of them have a known portfolio?
223 of the 224 firms list at least one portfolio company, 2,133 known investments between them.
Who can I reach at these firms?
1,197 people working at them have a profile here, each with their role at the firm and whether an email address is on file.
Where are most Clinical Trials investment firms based?
The largest concentrations are in New York, San Francisco and Boston.
What rounds do Clinical Trials investment firms take part in?
Most list Seed and Series A among their stages.
How do I contact Clinical Trials investment firms?
Every firm page shows whether an email address is on file, and the named contacts at that firm. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.
Is the list of Clinical Trials investment firms free to browse?
Yes. The directory and every firm page are free to read. Matching your own startup against them requires an account.
Do Clinical Trials funds only back Clinical Trials companies?
No. A focus area is a signal of interest, not a restriction. Firms usually list several, and the useful question is whether the existing portfolio looks like the kind of company you are building.
What is the difference between raising from a firm and raising from an angel?
An angel invests their own money and can decide alone, which usually makes the process shorter. A firm invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a firm once there is more to show.
Who should I contact at Clinical Trials investment firms?
A named partner or principal, not a general company address. Investment decisions sit with individual people, and a message that lands in a shared inbox usually stops there. Each fund page here lists the people we hold a profile for, with their role at the firm.
What does a portfolio tell me about a firm?
More than the description on its website. The companies a firm has already backed show the stage it really invests at, the kinds of business model it understands, and whether it has funded anything close to what you are building. Read the portfolio before you read the pitch page.
Do Clinical Trials investment firms invest outside the sectors they list?
Often, though not far outside. Sector tags describe where a firm concentrates rather than a rule it follows, and companies that sit between two categories get funded all the time. The stronger signal is whether the firm has backed a business with a similar shape, whatever label it carried.
How many firms should I approach?
Far more than feels comfortable. Response rates on cold outreach are low even when the fit is good, so a short list of perfect names tends to stall. Build a long list, sort it by how well each firm matches what you are building, and work down it in batches rather than sending everything at once.
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal